SKM-1 Cells
USD 500.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Información general
| Descripción | The SKM-1 cell line is a human leukemia model established from the peripheral blood of a patient with acute monoblastic leukemia that developed from myelodysplastic syndrome (MDS). These cells exhibit immature morphological features, such as a high nucleus-to-cytoplasm ratio and fine azurophilic granules, making them an excellent model for studying the molecular and cellular mechanisms of leukemia, particularly the transition from MDS to acute myeloid leukemia (AML). Genetic analysis of SKM-1 has revealed important chromosomal abnormalities, including del(9)(q13;q22) and der(17)t(17:?)(p13:?); the latter alteration involves the p53 gene, which is overexpressed and harbors mutations in this cell line. These findings highlight the role of p53 in clonal evolution and progression of myeloid malignancies. SKM-1 cells are also characterized by their expression of myelomonocytic markers, including CD4, CD13, and CD33, as well as their positivity for butyrate esterase activity, which aligns with their monoblastic lineage. This cell line is widely used in research on leukemogenesis, drug resistance, and the molecular pathways underlying leukemia. For instance, SKM-1 provides a platform for exploring the impacts of p53 dysfunction and other genetic lesions on cell proliferation and therapeutic response. It also serves as a model for investigating novel therapeutic strategies for myelodysplastic syndromes and secondary AML. |
|---|---|
| Organismo | Human |
| Tejido | Peripheral blood |
| Enfermedad | acute myleoid leukemia |
| Sinónimos | SKM1 |
Características
| Edad | 76 years |
|---|---|
| Género | Male |
| Origen étnico | Japanese |
| Morfología | Round cells |
| Propiedades de crecimiento | Suspension |
Datos normativos
| Referencia | SKM-1 (Cytion catalog number 305627) |
|---|---|
| Nivel de bioseguridad | 1 |
| NCBI_TaxID | 9606 |
| N.º de acceso de Cellosaurus | CVCL_0098 |
Datos biomoleculares
| Expresión de antígenos | CD3 -, CD4 (+), CD13 +, CD14 -, CD15 +, CD19 -, CD33 +, HLA-DR +; |
|---|---|
| Virus | EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -, SMRV - |
| Perfil mutacional | Mutation: ASXL1, Simple, p.Tyr591Ter (c.1773C>A), Homozygous; Mutation: BCORL1, Simple, c.4619-1G>A, Homozygous, Splice acceptor Mutation; Mutation: EZH2, Simple, p.Tyr646Cys (c.1937A>G), Heterozygous; Mutation: KRAS, Simple, p.Lys117Asn (c.351A>C), Homozygous; Mutation: TP53, Simple, p.Arg248Gln (c.743G>A), Homozygous |
Manejo
| Medio de cultivo | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suplementos | Supplement the medium with 15% FBS |
| Reactivo de disociación | None |
| Tiempo de duplicación | 48 hours |
| Densidad de siembra | 0.3 to 1 x 106 cells/ml |
| Renovación de fluidos | 2 to 3 times per week |
| Medio de congelación | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelación y cultivo de células |
|
| Atmósfera de incubación | 37°C, 5% CO2, humidified atmosphere. |
| Condiciones de envío | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condiciones de almacenamiento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Control de calidad y análisis molecular
| Esterilidad | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de análisis (CoA)
| Número de lote | Tipo de certificado | Fecha | Número de catálogo |
|---|---|---|---|
| 305627-060226 | Certificado de análisis | 05. Mar. 2026 | 305627 |
-
Related products
Related products
SK-BR-3 CellsOrganismo Human Tejido Breast, mammary gland Enfermedad Invasive ductal carcinoma USD 395.00*